These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 2898853)

  • 1. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels.
    Schmitz O
    Acta Endocrinol (Copenh); 1988 May; 118(1):125-34. PubMed ID: 2898853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
    Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
    Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of hyperglycemia on glucose uptake and hepatic glucose production in non-dialyzed uremic patients.
    Schmitz O; Arnfred J; Orskov L; Nielsen OH; Orskov H; Posborg V
    Clin Nephrol; 1988 Jul; 30(1):27-34. PubMed ID: 2905213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance.
    Berrish TS; Hetherington CS; Alberti KG; Walker M
    Diabetologia; 1995 Jun; 38(6):699-704. PubMed ID: 7672492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals.
    Matsuda M; Defronzo RA; Glass L; Consoli A; Giordano M; Bressler P; Delprato S
    Metabolism; 2002 Sep; 51(9):1111-9. PubMed ID: 12200754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of insulin resistance in Turner syndrome.
    Stoppoloni G; Prisco F; Alfano C; Iafusco D; Marrazzo G; Paolisso G
    Diabete Metab; 1990; 16(4):267-71. PubMed ID: 1979950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of tissue sensitivity to insulin in uraemic patients on long-term haemodialysis therapy.
    Schmitz O; Hjøllund E; Alberti KG; Orskov H; Beck-Nielsen H
    Diabetes Res; 1985 Mar; 2(2):57-63. PubMed ID: 4042532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.
    Saccà L; Cicala M; Trimarco B; Ungaro B; Vigorito C
    J Clin Invest; 1982 Jul; 70(1):117-26. PubMed ID: 6123524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man.
    Dirlewanger M; Schneiter PH; Paquot N; Jequier E; Rey V; Tappy L
    Clin Nutr; 2000 Feb; 19(1):29-34. PubMed ID: 10700531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the amylin analogue pramlintide on hepatic glucagon responses and intermediary metabolism in Type 1 diabetic subjects.
    Orskov L; Nyholm B; Yde Hove K; Gravholt CH; Møller N; Schmitz O
    Diabet Med; 1999 Oct; 16(10):867-74. PubMed ID: 10547215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
    Baron AD; Schaeffer L; Shragg P; Kolterman OG
    Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man.
    Paolisso G; Scheen AJ; Luyckx AS; Lefebvre PJ
    Am J Physiol; 1987 Jan; 252(1 Pt 1):E1-7. PubMed ID: 3544860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.
    Nielsen MF; Wise S; Dinneen SF; Schwenk WF; Basu A; Rizza RA
    Diabetes; 1997 Dec; 46(12):2007-16. PubMed ID: 9392488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin infusion enhances hepatic glucose production during hyperglucagonemia.
    Meneilly GS; Minaker KL; Elahi D; Rowe JW
    Metabolism; 1988 Mar; 37(3):252-6. PubMed ID: 2893970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior efficacy of pulsatile versus continuous hormone exposure on hepatic glucose production in vitro.
    Komjati M; Bratusch-Marrain P; Waldhäusl W
    Endocrinology; 1986 Jan; 118(1):312-9. PubMed ID: 3000741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased hepatic glucose production response to glucagon in trained subjects.
    Drouin R; Lavoie C; Bourque J; Ducros F; Poisson D; Chiasson JL
    Am J Physiol; 1998 Jan; 274(1):E23-8. PubMed ID: 9458743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.